Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $1.12T | Healthcare | Pharmaceuticals | United States | NYSE |
| 2 | $655.37B | Healthcare | Pharmaceuticals | United States | NYSE |
| 3 | $470.55B | Healthcare | Pharmaceuticals | United States | NYSE |
| 4 | $366.84B | Healthcare | Pharmaceuticals | United States | NYSE |
| 5 | $175.89B | Healthcare | Pharmaceuticals | United States | NYSE |
| 6 | $163.69B | Healthcare | Pharmaceuticals | United States | NYSE |
| 7 | $133.74B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 8 | $34.17B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 9 | $33.56B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 10 | $29.52B | Healthcare | Pharmaceuticals | United States | NYSE |
| 11 | $26.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 12 | $25.70B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 13 | $20.98B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 14 | $20.83B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 15 | $15.47B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 16 | $13.02B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 17 | $12.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 18 | $12.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 19 | $11.95B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 20 | $11.88B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 21 | $11.51B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 22 | $11.22B | Healthcare | Pharmaceuticals | United States | NYSE |
| 23 | $10.16B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 24 | $9.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 25 | $9.22B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 26 | $9.20B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 27 | $8.60B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 28 | $7.98B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 29 | $7.57B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 30 | $7.56B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 31 | $7.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 32 | $6.79B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 33 | $6.74B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 34 | $6.59B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 35 | $6.55B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 36 | $5.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 37 | $5.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 38 | $5.57B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 39 | $5.53B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 40 | $5.50B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 41 | $4.94B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 42 | $4.91B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 43 | $4.80B | Healthcare | Pharmaceuticals | United States | NYSE |
| 44 | $4.35B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 45 | $4.32B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 46 | $4.27B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 47 | $4.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 48 | $3.85B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 49 | $3.69B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 50 | $3.61B | Healthcare | Pharmaceuticals | United States | NYSE |
| 51 | $3.56B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 52 | $3.54B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 53 | $3.44B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 54 | $3.37B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 55 | $3.33B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 56 | $3.18B | Healthcare | Pharmaceuticals | United States | NYSE |
| 57 | $3.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 58 | $2.82B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 59 | $2.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 60 | $2.77B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 61 | $2.59B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 62 | $2.49B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 63 | $2.47B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 64 | $2.46B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 65 | $2.46B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 66 | $2.34B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 67 | $2.34B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 68 | $2.33B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 69 | $2.33B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 70 | $2.27B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 71 | $2.22B | Healthcare | Pharmaceuticals | United States | NYSE |
| 72 | $2.20B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 73 | $2.16B | Healthcare | Pharmaceuticals | United States | NYSE |
| 74 | $2.10B | Healthcare | Pharmaceuticals | United States | NYSE |
| 75 | $2.06B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 76 | $2.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 77 | $2.02B | Healthcare | Pharmaceuticals | United States | NYSE |
| 78 | $2.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 79 | $2.00B | Healthcare | Pharmaceuticals | United States | NYSE |
| 80 | $2.00B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 81 | $2.00B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 82 | $1.99B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 83 | $1.92B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 84 | $1.91B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 85 | $1.90B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 86 | $1.90B | Healthcare | Pharmaceuticals | — | Nasdaq |
| 87 | $1.85B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 88 | $1.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 89 | $1.79B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 90 | $1.69B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 91 | $1.68B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 92 | $1.65B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 93 | $1.60B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 94 | $1.59B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 95 | $1.53B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 96 | $1.44B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 97 | $1.44B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 98 | $1.42B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 99 | $1.41B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 100 | $1.38B | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 363 companies. Market capitalization in USD.